Tergus Gears Up for a Busy June
June is looking to be a very busy month for Tergus, particularly with CEO Vijendra Nalamothu speaking at the 6th AGAH Dermatological Product Development Workshop. The workshop will be held at the Cumberland Hotel in London on June 23rd and 24th and will be hosted by The Association for Applied Human Pharmacology.
This conference explores the field of innovative drug development and human pharmacology, and the topic that Vijendra will be discussing is as follows: “A Quality by Design Approach for Topical Formulation Development: Utilization of Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) that are linked to the Critical Quality Attributes (CQAs) in order to develop a topical product.”
Earlier in June, however, Tergus will be attending other conferences as well. June 8 – 13 is when the World Congress of Dermatology Technical Conference will be held in Vancouver, Canada. The Scientific Program Committee has committed to bringing global representation to a wide variety of subjects that are core to medical, surgical, and esthetic dermatology. There will be a vast range of special sessions to meet everyone’s interests. Young “Rising Star” dermatologists will be showcased in every session.
On June 15 – 18 is BIO 2015, which will be held at the Pennsylvania Convention Center in Philadelphia. The BIO Exhibition is the world’s largest biotechnology gathering that allows exhibitors to reach high-level executives and influential decision makers and to discover new players in the industry. It will feature more than 1,700 exhibitors and will be a prime scenario for companies and other participants to network. Vijendra will be giving two presentations on considerations for topical pharmaceuticals June 17th 11:00 a.m. and 11:30 a.m. at the NC Bio pavilion at the conference.
Tergus Pharma is excited to participate in these prestigious programs and to be a part of gatherings centered on issues from dermatological development to biotechnology.
We would love to see you if you are planning to be at any of these meetings. Email us at firstname.lastname@example.org to set up a time.
- Tergus Pharma Announces New Commercial Manufacturing Facility and Partnership with Great Point Partners
- Large vs. Small – Why small, agile manufacturing operations trump large companies
- SUPAC-SS GUIDANCE EXPLAINED – When In Vitro Release Testing (IVRT) is Required for Semisolid Products
- Continuous Manufacturing and Semi-Solids
- Skin Cancer Drug Fast-tracked to Patients in UK